Jose-Carlos Gutiérrez-Ramos, Ph.D., has served as a member of the Board of Directors since April 2022. Dr. Gutiérrez-Ramos has served as the Chief Science Officer at Danaher Corporation, a science and technology company, since January 2021. Prior to that, Dr. Gutiérrez‑Ramos was the Global Head of Global Drug Discovery at AbbVie, Chief Executive Officer and President of Repertoire Immune Medicine and Chief Executive Officer and President of Synlogic. Earlier in his career, Dr. Gutiérrez‑Ramos held executive research and development positions at Pfizer, GlaxoSmithKline, and Takeda. Dr. Gutierrez Ramos received a B.S. from Universidad Complutense de Madrid and his Ph.D. in immunochemistry from the Universidad Autonoma de Madrid.
Jose-Carlos Gutiérrez-Ramos, Ph.D.